10x Genomics (NASDAQ:TXG) Given New $12.00 Price Target at Barclays
10x Genomics (NASDAQ:TXG – Free Report) had its target price trimmed by Barclays from $15.00 to $12.00 in a research note released on Thursday morning,Benzinga reports. The brokerage currently has an overweight rating on the stock. Other analysts have also issued reports about the stock. Weiss Ratings restated a “sell (e+)” rating on shares of […]
10x Genomics (NASDAQ:TXG – Free Report) had its target price trimmed by Barclays from $15.00 to $12.00 in a research note released on Thursday morning,Benzinga reports. The brokerage currently has an overweight rating on the stock. Other analysts have also issued reports about the stock. Weiss Ratings restated a “sell (e+)” rating on shares of […]
